Kairui Feng

Kairui Feng

Auto-generated profile, based on publicly available information

Kairui Feng

A School of Chemical and Environmental Engineering , Shanghai Institute of Technology , Shanghai , China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KFKai-Rui Feng
Kai-Rui Feng
FWFeng Wang
Feng Wang
XSXin-Wei Shi
Xin-Wei Shi
YTYun-Xuan Tan
Yun-Xuan Tan
JZJia-Ying Zhao
Jia-Ying Zhao
PTPing Tian
Ping Tian

13 November 2018 in MedChemComm
Verified
Journal Article
Closed access
PDF file
SHShanshan Huang
Shanshan Huang
KFKairui Feng
Kairui Feng
YRYujie Ren
Yujie Ren
Matrix metalloproteinase-13 (MMP-13) is an attractive drug target for the treatment of osteoarthritis (OA). In this study, a series of quinazolinone derivatives as MMP-13 inhibitors were firstly systematically studied using QSAR, molecular docking and molecular dynamics (MD) simulation. The reliable CoMFA (q2 = 0.646, r2 = 0.992, Rpred 2 = 0.829) and CoMSIA (q2 = 0.704, r2 = 0.992, Rpred 2 = 0.839) models were constructed and verified by the Topomer CoMFA model. Results of contour maps indicated that the electrostatic, hydrophobic and H-bond acceptor fields primarily influenced the activity of MMP-13 inhibitors in the models. Several key residues (Ala238, Thr245, Thr247, Met253, Asn215 and Lys140) were identified as important factors to improve the activity and stability of the inhibitor through hydrogen bonding and electrostatic interaction. Based on these results, eight novel quinazolinones (D1–D8) were further designed. Additionally, all designed compounds showed good pharmacokinetic properties by ADMET predictions. Compounds D3 and D8 exhibited excellent predictive activity, and the 10 ns MD simulations analysis revealed that the hydrogen bonding interaction with residues (Ser250 and Gly248) was enhanced, and the small group in R2 and U-shaped conformation was of pivotal importance. These results provided strong guidance for the discovery and design of novel potential MMP-13 inhibitors.

15 December 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
XPXiu Xiu Peng
Xiu Xiu Peng
KFKai Rui Feng
Kai Rui Feng
YRYujie Ren
Yujie Ren
The forced expression of phosphoinositide 3-kinase δ (PI3Kδ) in B cells was found to be oncogenic, rendering PI3Kδ an attractive drug target for chronic lymphocytic leukaemia. This study aimed to systemically explore the interaction mechanism of novel quinazolinone scaffold-based derivatives as PI3Kδ inhibitors using 3D-QSAR, molecular docking, pharmacophore model and molecular dynamics (MD) simulations. The 3D-QSAR models CoMFA, CoMSIA and Topomer CoMFA were established to discover critical structural factors affecting PI3Kδ inhibitory activity. The models showed suitable reliabilities (q2 0.741, 0.712 and 0.711) and predictive abilities (rpred 2 0.851, 0.738 and 0.828, respectively). Contour maps indicated that the bioactivity of PI3Kδ inhibitor was affected most by electrostatic and hydrophobic fields. The Surflex-Dock and pharmacophore model result showed that enhancing the H-bond interaction of the key substituents around the 2- and 4-positions of pyrimidine with Glu826, Val828 and Asp911, as well as the electrostatic interactions of substituents around the 3-position of benzene with Ser831, Asp832 and Asn836, significantly affected the improvement in the activity and stability of the inhibitor. Based on these results, 10 novel PI3Kδ inhibitors with higher predicted activity and binding affinity were designed by introducing the heterocycles pyrrolopyridine or purine. 10 ns MD simulations further study the stable docking conformation of designed compounds, which showed strong hydrogen bond interactions with key residues Ser831 and Asp832 in a propeller-like fashion. These results provided strong guidance for the discovery and optimization of novel potent PI3Kδ selective inhibitors.

17 April 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
PQPing Ping Qian
Ping Ping Qian
SWShuai Wang
Shuai Wang
KFKai Rui Feng
Kai Rui Feng
YRYujie Ren
Yujie Ren
Human D-amino acid oxidase (h-DAAO) can effectively act on D-serine, which has been actively explored as a novel therapeutic target for treating schizophrenia. In this study, 37 h-DAAO inhibitors based on a 6-hydroxy-1,2,4-triazine-3,5(2H,4H)-dione scaffold were obtained to construct the optimal comparative molecular field analysis (CoMFA, q2 = 0.613, r2 = 0.966) and comparative molecular similarity index analysis (CoMSIA, q2 = 0.669, r2 = 0.985) models. The results indicate that the models have good predictability and strong stability. Furthermore, contour maps of the three-dimensional quantitative structure–activity relationship (3D-QSAR) revealed the relationships between the structural features and inhibitory activity. A total of nine new h-DAAO inhibitors were designed, which exhibited good predicted pIC50 values. Through molecular docking and molecular dynamics simulation, four essential residues (i.e., Gly313, Arg283, Tyr224 and Tyr228) were considered to interact with the inhibitor. The hydrogen bonds produced by the triazine structure with protein and the hydrophobic interactions with the residues (i.e., Leu51, His217, Gln53 and Leu215) play an important role in the stability of the inhibitor at the binding site of the protein. Additionally, the compounds D1, D3 and D8, with higher predicted activities, were selected by ADME and bioavailability prediction. The present study could offer a reliable theoretical basis for future structural optimisation, design and synthesis of effective antipsychotics.

19 July 2018 in Journal of the Taiwan Institute of Chemical Engineers
Verified
Journal Article
Closed access
LMLingwei Meng
Lingwei Meng
KFKairui Feng
Kairui Feng
YRYujie Ren
Yujie Ren

1 September 2017 in Journal of the Taiwan Institute of Chemical Engineers
Verified
Journal Article
Closed access
KFKairui Feng
Kairui Feng
YRYujie Ren
Yujie Ren
RLRen Li
Ren Li